drugset / Trial / NCT00770978
Open Label Study of Ceftobiprole to Evaluate Pharmacokinetics in Adults Hospitalized in the ICU
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this research study is to measure the levels of ceftobiprole in the blood and urine during and after administration of four doses of ceftobiprole. Safety of the drug will also be evaluated.
Timeline
- Start
- 2008-11
- Primary completion
- 2010-09
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ceftobiprole | Small molecule | 1000 mg | Intravenous |
Indications
No indication recorded.